Russia recorded more than 900 coronavirus deaths for second day in a row

Russia has registered 27,550 new cases of coronavirus in the past 24 hours, nearly 2,500 more than on Wednesday, as reported by the infectious disease center of that country.

These data continue the upward trend in infections in Russia, where more than 97% of the positives are due to the delta variant.

The highest number of new positives was recorded in Moscow, the epicenter of the pandemic in Russia, where 5,404 cases, against the 3,589 recorded the day before.

On the last day in the land they died 924 people for COVID-19, with which the number of daily deaths from infectious disease remains higher 900 for the second consecutive day.

In total, since the start of the pandemic, they have died in Russia 213,549 people, although official statistics on excessive deaths during the same period triple that figure.

On Tuesday, the Deputy Prime Minister of Russia and in charge of the fight against the pandemic, Tatiana Golikova, said they are currently registered three times more cases than in the same period of the previous year.

Russia, with 7 690 110 cases, it’s him fifth country in the world by number of confirmed infections, behind the United States, India, Brazil and the United Kingdom.

The authorities have so far ruled out the imposition of new health measures and have focused their efforts on promoting immunization. through awareness campaigns and raffles.

As of today, over 49 million citizens were vaccinated with the first dose (33.6% of the population) and 44.7 million received the full regimen (30.6% of the population).

On the other hand, the Nikolái Gamaleya Center for Epidemiology and Microbiology, who developed the vaccine against the Sputnik V coronavirus, tests of a combination drug against influenza and COVID-19 to begin at the end of 2022, as its director indicated this Thursday, Alexandre guintsbourg.

“The technological platform for this has already been created. The start of clinical trials of the new drug is scheduled for the end of next year, ”he said, in statements to the Russian newspaper. Izvestia.

Thus, Guíntsburg stressed that the future vaccine will be based on a hybrid rotavirus drug and added that in parallel a drug against various variants of the coronavirus. Other Russian centers, including the Vector Center, are also developing a combined vaccine against influenza and COVID-19.

(With information from EFE and Europa Press)

KEEP READING: